Division of Clinical Epidemiology and Aging Research, German Cancer Research Center, Heidelberg, Germany.
Eur J Public Health. 2011 Apr;21(2):221-8. doi: 10.1093/eurpub/ckq031. Epub 2010 Apr 21.
The EUROCARE study has disclosed large variations of survival across Europe, with the magnitude varying, depending on cancer site. Comparisons of these rates with those from the developing countries are rare, but important in evaluating international cancer care discrepancies. This study aimed to provide up-to-date estimates of cancer survival in a Philippine urban population, and to compare these with those observed in the European countries.
Using the results from the EUROCARE-4 study, the survival estimates of the European patients who were diagnosed in 1995-99 and followed till December 2003 were abstracted. From randomly selected samples drawn from the Manila and Rizal Cancer Registries, 5-year survival was estimated for nine common cancers. Age-adjusted survival estimates were then compared between the Philippine population and Europeans.
In comparison to the European mean, survival estimates for the Philippine residents were lower for most cancers, with differences ranging from 2 to 40% units. Differences with European country-specific estimates were large for cancers of the breast and cervix, where early detection is possible, and for leukaemia, where treatment regimens are costly, highlighting the importance of health care. Smaller discrepancies were observed for stomach, liver and lung cancers, with the 5-year relative survival being similar to the Philippines and to many European countries. A survival advantage was seen though for the Philippine residents for ovarian cancer.
Apart from efforts to prevent cancers, improvements in cancer control and making early diagnosis and treatment more accessible remain major challenges, both in the Philippines and in the European nations.
EUROCARE 研究揭示了欧洲各地生存率的巨大差异，其幅度因癌症部位而异。与发展中国家的这些比率进行比较很少见，但对于评估国际癌症护理差异很重要。本研究旨在提供菲律宾城市人口癌症生存的最新估计，并将这些估计与欧洲国家观察到的结果进行比较。
利用 EUROCARE-4 研究的结果，提取了 1995-99 年诊断并随访至 2003 年 12 月的欧洲患者的生存估计值。从马尼拉和黎刹癌症登记处随机抽取样本，估计了 9 种常见癌症的 5 年生存率。然后比较菲律宾人群和欧洲人的年龄调整后生存率估计值。
与欧洲平均水平相比，菲律宾居民的大多数癌症的生存率估计值较低，差异范围为 2%至 40%。与欧洲特定国家的估计值差异较大的癌症包括乳腺癌和宫颈癌，这些癌症可以早期发现，以及白血病，这些癌症的治疗方案昂贵，突出了医疗保健的重要性。对于胃癌、肝癌和肺癌，差异较小，5 年相对生存率与菲律宾和许多欧洲国家相似。然而，菲律宾居民的卵巢癌生存率存在优势。
除了预防癌症的努力外，改善癌症控制并使早期诊断和治疗更容易获得仍然是菲律宾和欧洲国家面临的主要挑战。
